Insider trades

Scalzo Richard William, CFO of Crescent Biopharma CBIO, has filed 0 purchases and 37 sales on the open market. Over the past 12 months that comes to a net sale of $20K. The latest trade was on 06/22.

Scalzo Richard William

CFO
First filing
23/03/15
Trades
72 trades
Buys / sales
0 / 37
12-month net buying
−$20K
Last trade
06/22

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/2206/231,112 sh$17.99$20,004.88−5.2%
Open-market sale10b5-1 plan25/03/1125/03/131,343 sh$11.38$15,283.34−1.1%
Open-market sale10b5-1 plan25/03/0525/03/07917 sh$11.83$10,848.11−0.7%
Open-market sale10b5-1 plan25/02/1825/02/182,488 sh$13.95$34,707.6−2.0%
Open-market sale10b5-1 plan24/12/1124/12/111,455 sh$28.12$40,914.6−1.1%
Open-market sale10b5-1 plan24/11/1824/11/182,735 sh$28.20$77,127−2.8%
Open-market sale10b5-1 plan24/09/1824/09/191,390 sh$34.55$48,024.5−1.4%
Open-market sale10b5-1 plan24/09/1124/09/111,468 sh$31.89$46,814.52−1.4%
DYN
Open-market sale24/09/0624/09/10126,074 sh2 trades$32.15avg.$4,052,851.36−55.4%
DYN
Open-market sale10b5-1 plan24/08/1924/08/202,752 sh2 trades$45.12avg.$124,174.42−2.4%
DYN
Open-market sale10b5-1 plan24/06/10–24/06/1124/06/112,921 sh2 trades$30.74avg.$89,779.24−2.5%
DYN
Open-market sale10b5-1 plan24/05/1624/05/172,588 sh2 trades$28.27avg.$73,161.78−2.2%
DYN
Open-market sale10b5-1 plan24/03/08–24/03/1124/03/1288,924 sh5 trades$26.19avg.$2,329,006.68−42.7%
Open-market sale10b5-1 plan24/03/0724/03/112,273 sh$25.85$58,757.05−1.8%
DYN
Open-market sale10b5-1 plan24/02/29–24/03/0124/03/0112,740 sh3 trades$28.05avg.$357,296.44−9.3%
Open-market sale10b5-1 plan24/01/2624/01/2613,000 sh$24.34$316,420−9.5%
Open-market sale10b5-1 plan24/01/0324/01/0413,000 sh$18.81$244,530−9.5%
Open-market sale10b5-1 plan23/12/1423/12/142,376 sh$12.02$28,559.52−1.9%
Open-market sale23/12/1123/12/121,380 sh$10.72$14,793.6−1.1%
DYN
Open-market sale10b5-1 plan23/12/04–23/12/0623/12/062,553 sh2 trades$12.01avg.$30,661.53−2.0%